Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 2, 2025

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

4.1K

Testis-sparing Surgery: A Single Institution Experience.

Jillian Egan1, Joseph G Cheaib2, Michael J Biles2

  • 1Department of Urology, MedStar Georgetown University Hospital, Washington, DC.

Urology
|November 2, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same author

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same author

Giant Cell Urothelial Carcinoma: Morphometric Insights and Associations With Aggressive Clinical Features.

The American journal of surgical pathology·2026
Same author

Trends in Industry-Sponsored Research Payments to Otolaryngologist Principal Investigators.

The Laryngoscope·2026
Same author

Renal Cell Carcinoma With Concurrent Loss of SMARCB1/INI-1 and Fumarate Hydratase By Immunohistochemistry: A Case Report With Review of the Literature.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

Clinicopathologic spectrum of renal-pelvic fibroepithelial polyps: A series of five patients with emphasis on mimicry of malignancy.

Human pathology·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
Same journal

Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

Urology·2026
Same journal

Intractable Epistaxis and Severe Hypertension in a Young Woman.

Urology·2026
Same journal

A 53-Year-Old Man with Elevated PSA and a Cystic Pelvic Lesion.

Urology·2026
Same journal

Low-Grade, Papillary Bladder Tumors A plea for in-office fulguration.

Urology·2026
See all related articles

Testis-sparing surgery (TSS) is safe and effective for small benign testicular masses and in cases of bilateral disease or germ cell tumors in a solitary testicle. This approach preserves testicular function and offers good oncological outcomes.

Area of Science:

  • Urology
  • Oncology
  • Surgical Pathology

Background:

  • Testis-sparing surgery (TSS) is an option for specific testicular conditions.
  • Evaluating the safety and efficacy of TSS is crucial for patient outcomes.

Purpose of the Study:

  • To assess the safety and efficacy of testis-sparing surgery (TSS).
  • To evaluate TSS in cases of small, nonpalpable masses suspected to be benign.
  • To assess TSS for masses suspicious for germ cell tumor in a solitary or functionally solitary testicle or bilateral disease.

Main Methods:

  • Retrospective review of a testicular cancer registry (2013-2020).
  • Analysis of attempted versus completed TSS procedures.
  • Statistical comparison using Student's t test, chi-squared, Fisher's exact, and Wilcoxon rank-sum tests.

More Related Videos

A Modified Vessel-Sparing Microsurgical Vasoepididymostomy
04:59

A Modified Vessel-Sparing Microsurgical Vasoepididymostomy

Published on: June 8, 2022

2.2K
Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration
07:21

Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration

Published on: February 10, 2023

2.9K

Related Experiment Videos

Last Updated: Dec 2, 2025

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

4.1K
A Modified Vessel-Sparing Microsurgical Vasoepididymostomy
04:59

A Modified Vessel-Sparing Microsurgical Vasoepididymostomy

Published on: June 8, 2022

2.2K
Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration
07:21

Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration

Published on: February 10, 2023

2.9K

Main Results:

  • TSS was attempted in 28 patients and completed in 14.
  • Frozen section analysis had 100% sensitivity and 93% specificity.
  • Testis sparing rates were 41% for unilateral masses and 83% for bilateral disease or solitary testis tumors.
  • At median follow-up, 96% of patients had no evidence of disease.

Conclusions:

  • Testis-sparing surgery (TSS) is a safe and effective option for select patients.
  • TSS is particularly beneficial for small, benign testicular masses.
  • TSS is also effective in managing bilateral testicular disease or germ cell tumors in a solitary testis.